Skip to content

Advertisement

  • Research article
  • Open Access
  • Open Peer Review

What is it about a cancer diagnosis that would worry people? A population-based survey of adults in England

  • 1,
  • 1,
  • 1 and
  • 1Email author
BMC Cancer201818:86

https://doi.org/10.1186/s12885-017-3963-4

©  The Author(s). 2018

  • Received: 25 April 2017
  • Accepted: 7 December 2017
  • Published:
Open Peer Review reports

Abstract

Background

Surveys indicate quite high prevalence of cancer worry in the general population, but little is known about what it is about cancer that worries people. A better understanding of the origins of cancer worry may help elucidate previously found inconsistencies in its behavioural effect on cancer prevention, screening uptake, and help-seeking for symptoms. In this study, we explore the prevalence and population distribution of general cancer worry and worries about specific aspects of cancer previously identified.

Methods

A population-based survey of 2048 English adults (18–70 years, April–May 2016), using face-to-face interviews to assess demographic characteristics, general cancer worry and twelve sources of cancer worry (adapted from an existing scale), including the emotional, physical, and social consequences of a diagnosis.

Results

In general, a third of respondents (37%) never worried about cancer, 57% worried occasionally/sometimes, and 6% often/very often. In terms of specific worries, two thirds would be ‘quite a bit’ or ‘extremely’ worried about the threat to life and emotional upset a diagnosis would cause. Half would worry about surgery, radiotherapy, chemotherapy, and loss of control over life. Worries about the social consequences were less commonly anticipated: just under half would worry about financial problems or their social roles, and a quarter would be worried about effects on identity, important relationships, gender role, and sexuality. Women and younger people reported more frequent worry about getting cancer, and would be more worried about the emotional, physical, and social consequences of a cancer diagnosis (p < .001). Those from ethnic minority backgrounds reported less frequent worry about getting cancer than their white counterparts, but would be equally worried about the emotional and physical impact of a cancer diagnosis, and worried more about the social consequences of a cancer diagnosis (p < .05).

Conclusions

The majority of English adults worry at least occasionally about getting cancer, and would be most worried about the emotional and physical impact of a cancer diagnosis. Distinguishing between the various worries that cancer can evoke may help inform efforts to allay undue worries in those who are deterred by them from engaging with cancer prevention and early detection.

Keywords

  • Cancer
  • Oncology
  • Worry
  • Fear
  • Screening
  • Early detection
  • Prevention

Background

Population surveys in the UK and US show that 25–50% of people worry about getting cancer), with 5 to 10% being extremely worried [1–3]. Cancer worry, defined as a negative emotional reaction to the threat of cancer [4], is often operationalised as a unidimensional construct. Studies usually measure its frequency [5–7], intensity [3, 5, 8], the physical experiences associated with this negative emotional reaction, such as fear or anxiety [3, 9], or a combination [5]. However, little is known about whether there could be different aspects of cancer that evoke different worries in people in the general population.

Cancer worry in the general population has been shown to affect uptake of cancer screening [4, 10], help-seeking for possible cancer symptoms [11, 12], and adoption of cancer-preventive health behaviours [1]. However, some of these studies have found that worry is a motivator and others that it is a deterrent. Some authors have suggested that it may be necessary to identify the specific origins of cancer-related worry to make sense of the inconsistencies observed in cancer worry’s behavioural effects [4, 13].

The idea that the behavioural effect of worry is dependent on its source, is consistent with health behaviour theories that assign a central role to efficacy beliefs in dealing with a threat, such as Witte’s Extended Parallel Process Model (EPPM) [14] or Rogers’ Protection Motivation Theory [15]. For example, according to Witte’s EPPM, the response to a perceived threat is dependent on the outcome of an efficacy appraisal, including beliefs about self- and response-efficacy. If efficacy is high, the behavioural response will aim to avert the danger associated with the threat. If efficacy is low, the behavioural response will aim to decrease the fear associated with the threat, rather than the threat itself. Since efficacy beliefs are guided by the nature of the threat, it follows that the behavioural response may differ. An example of this is a US-based study of prostate cancer screening which found that worry about prostate cancer was associated with more frequent screening to obtain reassurance, while fear of screening led to less frequent screening [16]. This study suggests that deterring effects of screening fears could be addressed by increasing efficacy beliefs about screening (e.g. self-efficacy). If, on the other hand, interventions were developed to reduce worry about prostate cancer, for example, by developing strategies to cope with prostate cancer worry, then this could be expected to result in lower screening uptake. Although this study measured fear of the screening procedure itself rather than fear of screening outcomes, it highlights the need for a more precise and comprehensive definition and operationalisation of ‘cancer worry’ in the general population. Because 1 in 2 people in the UK born after 1960 are expected to develop cancer within their lifetime [17], it is important to understand how cancer-related worries in those without a cancer diagnosis in the general population may affect behaviours such as screening uptake and help-seeking for symptoms to inform efforts to increase informed participation in cancer prevention and early detection. However, as the above study shows [16], interventions to increase efficacy in dealing with the threat of cancer would likely depend on the nature of the worry cancer evokes.

In contrast to population-based studies about cancer screening and public health, studies in cancer patients already tend to operationalise fear of cancer recurrence1 as a multidimensional construct, including fears about further treatment, loss of autonomy, and the effects of a recurrence on social activities, work, the partner, or the family [18–20]. Studies in those seeking help for possible cancer symptoms also suggest multidimensionality, including fears about the physical and financial consequences of cancer treatment, suffering, body disfigurement, leaving others behind, and death [11, 12, 21, 22]. Thus, in these subpopulations, cancer appears to evoke a wide range of fears.

Evidence that cancer worry may also be multidimensional in the general population comes from a recent systematic review of 102 qualitative studies carried out in the context of cancer screening [23]. In those eligible for screening, cancer worry manifested itself as a general worry about cancer, or as specific worries, such as about the emotional and physical consequences of a diagnosis (for example, chemotherapy and surgery), the social consequences of a diagnosis, or dying from cancer. Thus, this review suggests that cancer worry in the general population may have various specific origins. However, the qualitative nature of this review prevents any conclusions about the prevalence, population distribution, or behavioural effects of these different types of worry.

The present study aims to provide a starting point to exploring the usefulness of distinguishing between different origins of cancer worry in the general population who have not been diagnosed with cancer, by examining their prevalence and whether responses vary by demographic group. We chose to focus on twelve specific cancer worries that were commonly reported in the aforementioned qualitative review of the literature about cancer screening in the general population, and may therefore be hypothesised to be main cancer worries among the general population [23]. We also compare anticipated worries about these twelve aspects of a cancer diagnosis with a commonly-used measure of general cancer worry [24]. Previous studies have shown that general cancer worry is higher in women, in those who are younger, and in those from more deprived or ethnic minority backgrounds [16, 25–27].

Methods

Design and procedure

Data were collected as part of the third wave of the Attitudes, Behaviour, and Cancer UK Survey (ABACUS), using home-based face-to-face computer-assisted interviews conducted by market research agency TNS Research International as part of their weekly omnibus survey. This survey uses random location sampling of sample points defined by the 2011 Census small area statistics and the Postcode Address File. At each location, quotas are set for age, gender, working status, and children in the household.

Participants

Interviews with 2048 adults aged 18–70 years were conducted in the respondents’ homes in England in April and May 2016. This age range was chosen to reflect the adult population in England, but since the survey was part of a module about attitudes towards cancer and cancer screening, the upper age limit was set at 70 years because this is the age at which people stop being invited to cancer screening in England. Ethical approval was obtained from the UCL Research Ethics Committee (registration number 5771/002), and participants consented to participate at the start of the interview. Those who were diagnosed with cancer were excluded from the cancer worry questions to avoid distress.

Measures

General cancer worry was assessed with the question: ‘How often do you worry about your chance of getting cancer yourself?’, which was scored on a 5-point scale (never to very often). This item was adapted from the US Health and Information National Trends Survey [24] and has been used in many previous studies (e.g. [7, 28, 29]).

The sources of cancer worries described by those eligible for screening in the review [23] showed great overlap with those mentioned by cancer survivors. Thus, we decided to assess these specific worries about cancer using items adapted from the Concerns About Recurrence Scale (CARS) [20]. The CARS is a validated and internally reliable 30-item scale to assess breast cancer survivors’ concerns about recurrence, which we adapted through a process of cognitive interviewing and online piloting with asymptomatic adults in England for use in a general population sample without a previous diagnosis of cancer (see Additional file 1). We included twelve items in our survey that covered a wide range of specific cancer worries that are also reported by those seeking help for possible cancer symptoms [11, 21, 22] or those eligible for cancer screening [23]. Because cancer worry in the general population is predicated on the threat of cancer (for example, evoked by an invitation to cancer screening or the discovery of a symptom that may indicate cancer), all items started with the phrase “If you were diagnosed with cancer, would you worry that…?” and were measured on a 4-point scale (not at all to extremely). An exploratory factor analysis showed items loaded onto two factors: worries about the emotional and physical consequences of a cancer diagnosis (such as worries about the emotional upset that a cancer diagnosis would cause, and about chemotherapy and surgery), and worries about its social consequences (such as worries about the effect on relationships with family and friends, interference with sense of sexuality, and financial problems). The twelve items and factor loadings are presented in Additional file 2. Both subscales had good internal reliability (Cronbach’s α = .88 and α = .85, respectively). We calculated mean sub-scale scores for those with complete data on all twelve items.

Age, gender, ethnicity, marital status, and socioeconomic status were assessed with simple questions. Ethnicity was recorded using the 2011 Census question, and recoded as ‘White’ or ‘Black, Asian, and Minority Ethnic’ (BAME; any non-White or mixed ethnic background). Marital status was recorded as: ‘married or living as married’, ‘single’, and ‘widowed, divorced, or separated’. Social grade, an indicator of socioeconomic status (SES), was recorded in four categories using the National Readership Survey grades, which is based on details regarding the occupation of a household’s chief income earner [30]: ‘AB’ (Higher and intermediate managerial, administrative, and professional), ‘C1’ (Supervisory, clerical and junior managerial, administrative, or professional), ‘C2’ (skilled manual workers), and ‘DE’ (semi-skilled and unskilled manual workers; and state pensioners, casual and lowest grade workers, and unemployed with state benefits only). ‘Don’t know’ or ‘refused’ responses were coded as missing throughout.

Analyses

We excluded those with a cancer diagnosis or refusing to answer this question, as well as those with missing data on the demographic and general cancer worry variables. We report the descriptive characteristics of the sample, including prevalence numbers, applying weights to the data to adjust for sampling bias in relation to age, gender, government region, social grade, and working status.

We examined the population distribution of general cancer worry and the two specific worries scales using unweighted data for the univariate and multivariate linear regression models. A sensitivity analysis using weighted data did not change the pattern or significance of the results, so we report the unweighted results. We also conducted subgroup analyses to examine whether the demographic pattern of specific cancer worries differed between those who never worry about their chance of getting cancer versus those who worry at least occasionally, using a dichotomised version of the general cancer worry item. Lastly, we examined the correlations between general cancer worry and the specific worries subscales, and compared mean scores using multiple t-tests with a Bonferroni correction for multiple testing. All analyses were conducted in SPSS version 23, and an overall alpha level of 0.05 to indicate significance.

Results

In total, 2048 respondents were interviewed; after excluding those with a cancer diagnosis (n = 97; 4.7%), refusing to answer this question (n = 24; 1.2%), or with missing data on the demographic (n = 10; 0.5%) or general cancer worry variables (n = 27; 1.3%) 1890 were left for analysis (N = 1894 after weighting). Weighted sample characteristics are presented in Table 1.
Table 1

Characteristics of the weighted samples

 

General cancer worry (N = 1894)

Specific cancer worries (N = 1782)

Characteristic

N (%)a

N (%)a

Age

 Mean, SD

42.8 (15.3)

42.9 (15.3)

 Range

18–70

18–70

Gender

 Male

936 (49.4)

884 (49.6)

 Female

957 (50.6)

898 (50.4)

Ethnicity

 White

1596 (84.3)

1513 (84.9)

 BAMEb

298 (15.7)

269 (15.1)

Social grade

 AB (highest)

505 (26.7)

486 (27.3)

 C1

528 (27.9)

499 (28.0)

 C2

425 (22.4)

392 (22.0)

 DE (lowest)

436 (23.0)

405 (22.7)

Marital status

 Married or living as married

1194 (63.1)

1122 (63.0)

 Single

522 (27.5)

490 (27.5)

 Widowed, separated, or divorced

178 (9.4)

170 (9.5)

General cancer worry (frequency)

 Never

701 (37.0)

658 (36.9)

 Occasionally

657 (34.7)

618 (34.7)

 Sometimes

415 (21.9)

390 (21.9)

 Often

85 (4.5)

82 (4.6)

 Very often

36 (1.9)

34 (1.9)

Specific cancer worries (12 items)

 Complete data

1782 (94.1)

1782 (100.0)

 Missing data

112 (5.9)

–

aUnless otherwise stated

bBAME Black, Asian, and Minority Ethnic

General cancer worry

Just over a third of respondents (37%) never worried about getting cancer, 35% worried occasionally, 22% sometimes, 5% often, and 2% very often. Univariate and multivariate linear regression analyses showed that general cancer worry was less frequent in those who were older and from non-White ethnic backgrounds, and more frequent in women (Table 2). There were no differences by social grade or marital status.
Table 2

Mean scores and demographic correlates of general cancer worry (range: 1–5; unweighted data; N = 1890)

Characteristic

General cancer worry

Univariate$

 

Multivariate$,a

 

M (SD)

B (SE)

β

Significance

B (SE)

β

Significance

Total sample

1.99 (0.98)

      

Age

 

−.003 (.001)

−.053

p < .05

−.004 (.002)

−.071

p < .01

Gender

 Male

1.87 (0.94)

Ref

  

Ref

  

 Female

2.10 (1.02)

.226 (.045)

.115

p < .001

.214 (.046)

.108

p < .001

Ethnicity

 White

2.02 (0.98)

Ref

  

Ref

  

 BAMEb

1.88 (1.00)

−.141 (.062)

−.052

p < .05

−.164 (.063)

−.061

p < .01

Social grade

 AB (highest)

2.00 (0.90)

Ref

  

Ref

  

 C1

1.97 (0.95)

−.039 (.050)

−.081

p = .43

−.039 (.069)

−.018

p = .58

 C2

2.00 (0.97)

.001 (.055)

.0003

p = .99

−.007 (.073)

−.003

p = .92

 DE (lowest)

2.02 (1.07)

.032 (.048)

.015

p = .51

.027 (.069)

.013

p = .69

Marital status

 Married or living as married

2.01 (0.97)

Ref

  

Ref

  

 Single

1.97 (1.00)

−.034 (.050)

−.016

p = .50

−.074 (.055)

−.034

p = .18

 Widowed/separated/divorced

1.96 (1.04)

−.044 (.073)

−.014

p = .55

−.049 (.078)

−.016

p = .53

R2 = .021

$Values in bold are significant at p < .05

aMutually adjusted for age, gender, ethnicity, social grade, and marital status

bBAME = Black, Asian, and Minority Ethnic

Specific cancer worries

A further 117 respondents (6.2%) were excluded because of missing data on the specific cancer worries items (Table 1). If diagnosed with cancer, about two thirds said they would be ‘quite a bit’ or ‘extremely’ worried about the threat to life and emotional upset that a cancer diagnosis would cause (Table 3). About half would be worried about surgery, radiation treatment, chemotherapy, and the loss of control over life. Worries about the social implications of a cancer diagnosis were less frequently anticipated: slightly less than half would be worried about financial problems or their social roles, while only about a quarter would be worried how cancer would affect their identity, important relationships, and sexuality. Only a fifth would worry about how a diagnosis of cancer would affect their gender role.
Table 3

Response rates and distributions for the specific cancer worry items (weighted; N = 1894)

If you were diagnosed with cancer, would you worry that...

Response rate

N (%)

Not at all

N (%)

Slightly

N (%)

Quite a bit

N (%)

Extremely

N (%)

Worries about the emotional and physical consequences

 1.you would require surgery?

1796 (94.8)

349 (19.4)

513 (28.6)

592 (33.0)

342 (19.0)

 2.it would upset you emotionally?

1799 (95.0)

190 (10.6)

443 (24.6)

616 (34.2)

550 (30.5)

 3.you would require chemotherapy?

1796 (94.8)

292 (16.3)

455 (25.3)

659 (36.7)

390 (21.7)

 4.you would require radiation treatment?

1799 (95.0)

337 (18.7)

497 (27.6)

636 (35.4)

329 (18.3)

 5.it would make you feel that you don’t have control over your life?

1794 (94.7)

335 (18.7)

551 (30.7)

540 (30.1)

368 (20.5)

 6.it would threaten your life?

1799 (95.0)

211 (11.7)

373 (20.7)

638 (35.5)

577 (32.1)

Worries about the social consequences

 7.it would make you feel less of a (wo)man?

1799 (95.0)

1044 (58.1)

416 (23.1)

230 (12.8)

109 (6.1)

 8.it would interfere with your sense of sexuality?

1800 (95.0)

868 (48.2)

467 (25.9)

326 (18.1)

139 (7.7)

 9.it would threaten your identity?

1795 (94.8)

781 (43.5)

507 (28.2)

359 (20.0)

148 (8.2)

 10.it would hurt your relationships with friends and family?

1800 (95.0)

814 (45.2)

482 (26.8)

329 (18.3)

175 (9.7)

 11.it would cause financial problems for you?

1797 (94.9)

425 (23.6)

510 (28.4)

531 (29.5)

331 (18.4)

 12.it would keep you from fulfilling important roles?

1797 (94.9)

361 (20.1)

548 (30.5)

566 (31.5)

322 (17.9)

Worries about the emotional and physical consequences

The sample mean for worries about the emotional and physical consequences of a cancer diagnosis was 2.65/4 (SD 0.80), equating to a score between ‘slightly’ and ‘quite a bit’ (Table 4). In univariate and multivariate analyses, women and those who were younger were more likely to anticipate worrying about the emotional and physical consequences of a cancer diagnosis, while those from social grade DE were less likely to anticipate worry about this compared with social grade AB, but there were no differences by ethnicity, marital status, or social grades C1 and C2.
Table 4

Mean scores and demographic correlates of worries about the emotional and physical consequences of a cancer diagnosis (range: 1–4; unweighted; N = 1773)

Characteristic

Emotional and physical worries

Univariate$

 

Multivariate$,a

 

M (SD)

B (SE)

β

Significance

B (SE)

β

Significance

Total sample

2.65 (0.80)

      

Age

 

−.007 (.001)

−.143

p < .001

−.007 (.001)

−.148

p < .001

Gender

 Male

2.51 (0.76)

Ref

  

Ref

  

 Female

2.77 (0.82)

.256 (.038)

.159

p < .001

.246 (.038)

.153

p < .001

Ethnicity

 White

2.65 (0.79)

Ref

  

Ref

  

 BAMEb

2.62 (0.86)

−.030 (.053)

−.013

p = .57

−.076 (.053)

−.034

p = .15

Social grade

 AB (highest)

2.70 (0.77)

Ref

  

Ref

  

 C1

2.69 (0.78)

.052 (.042)

.029

p = .22

−.050 (.057)

−.028

p = .38

 C2

2.68 (0.80)

.034 (.046)

.017

p = .47

−.042 (.060)

−.022

p = .48

 DE (lowest)

2.57 (0.84)

−.113 (.041)

−.066

p < .01

−.155 (.057)

−.090

p < .01

Marital status

 Married or living as married

2.64 (0.79)

Ref

  

Ref

  

 Single

2.69 (0.84)

.049 (.042)

.028

p = .24

.005 (.046)

.003

p = .91

 Widowed/separated/divorced

2.60 (0.80)

−.052 (.061)

−.020

p = .40

.057 (.065)

.022

p = .37

R2 = .050

$Values in bold are significant at p < .05

aMutually adjusted for age, gender, ethnicity, social grade, and marital status

bBAME = Black, Asian, and Minority Ethnic

Subgroup analyses showed that anticipated worry about the emotional and physical consequences of a cancer diagnosis was significantly higher in those who worried at least occasionally versus those who never worried about their chance of getting cancer (M = 2.86, SD 0.71 vs M = 2.31, SD 0.84; t(1229) = −14.22, p < .001). Worry about the emotional and physical consequences was associated with younger age in both groups, and with being female in the group who worry at least occasionally about getting cancer (all p < .01; Additional file 3). There were no associations with ethnicity, social grade, or marital status for either group.

Worries about the social consequences

The sample mean for worries about the social consequences of a cancer diagnosis was 2.04/4 (SD 0.75), equating to feeling slightly worried (Table 5). Univariate and multivariate analyses showed that women, those who were younger, and those from BAME groups anticipated greater worry about the social consequences. Those who were single would be more worried about the social consequences of a cancer diagnosis than those who were married in unadjusted analyses, but this relationship was attenuated by adjusting for other demographic differences. There was no association with social grade.
Table 5

Mean scores and demographic correlates of worries about the social consequences of a cancer diagnosis (range: 1–4; unweighted; N = 1773)

Characteristic

Social worries

Univariate$

 

Multivariate$,a

 

M (SD)

B (SE)

β

Significance

B (SE)

β

Significance

Total sample

2.04 (0.75)

      

Age

 

−.011 (.001)

−.239

p < .001

−.011 (.001)

−.226

p < .001

Gender

 Male

1.95 (0.72)

Ref

  

Ref

  

 Female

2.12 (0.77)

.171 (.035)

.114

p < .001

.160 (.035)

.107

p < .001

Ethnicity

 White

2.01 (0.73)

Ref

  

Ref

  

 BAMEb

2.24 (0.83)

.226 (.049)

.108

p < .001

.153 (.049)

.073

p < .01

Social grade

 AB (highest)

1.99 (0.72)

Ref

  

Ref

  

 C1

2.05 (0.74)

.009 (.039)

.006

p = .82

−.010 (.052)

−.006

p = .84

 C2

2.11 (0.74)

.083 (.043)

.046

p = .05

.086 (.055)

.047

p = .12

 DE (lowest)

2.02 (0.78)

−.034 (.038)

−.021

p = .38

−.012 (.052)

−.008

p = .82

Marital status

 Married or living as married

2.02 (0.73)

Ref

  

Ref

  

 Single

2.13 (0.78)

.128 (.039)

.078

p < .01

.006 (.042)

.003

p = .90

 Widowed/separated/divorced

1.95 (0.75)

−.109 (.057)

−.045

p = .06

.047 (.059)

.019

p = .43

R2 = .076

$Values in bold are significant at p < .05

aMutually adjusted for age, gender, ethnicity, social grade, and marital status

bBAME = Black, Asian, and Minority Ethnic

Subgroup analyses showed that anticipated worry about the social consequences of a cancer diagnosis was significantly higher in those who worried at least occasionally compared with those who never worried about their chance of getting cancer (M = 2.20, SD 0.73 vs M = 1.78, SD 0.71; t(1771) = −11.81, p < .001). In both groups, being worried about the social consequences of a cancer diagnosis was associated with younger age (Additional file 3). For those who worried at least occasionally about getting cancer, worry about the social consequences was also associated with being female and being from an ethnic minority background. As per the main analyses, there were no associations with social grade or marital status.

The relationships between general cancer worry and the specific cancer worries

Anticipated worry about the emotional and physical consequences of a cancer diagnosis (M = 2.65/4, SD = 0.80) was significantly higher than worry about the social consequences of a cancer diagnosis (M = 2.04/4, SD = 0.75; t(1772) = 41.2, p < .001), or general cancer worry (M = 2.00/5, SD = 0.98; t(1772) = 26.6, p < .001). There was no difference between the latter two (t(1772) = 1.81, p = .07). The correlations between general cancer worry and the two specific cancer worries sub-scales were moderate: r = .349 (p < .001; emotional and physical consequences) and r = .305 (p < .001; social consequences). However, the two sub-scales of specific cancer worries were strongly correlated (Pearson’s r = .683, p < .001).

Discussion

This is the first study to examine the prevalence and demographic distribution of specific worries about cancer in the general population, and to compare this with general cancer worry. Nearly two thirds of the English adult population without a cancer diagnosis worry at least occasionally about getting cancer, and a fifth to two thirds anticipated worrying about specific aspects of the cancer experience if they were diagnosed. The population distributions for these worries partly overlap, but there may be important implications for future research where they diverge, as described below.

The prevalence and population distribution of general cancer worry in our study was similar to other population-based studies in the UK and US [25, 27, 31], with higher general cancer worry in women and those who are younger [25–27, 32]. The gender difference in cancer worry may be partly explained by women being more anxious in general [33], although previous studies found only moderate correlations between cancer worry and general anxiety [16, 27]. Little is known about the negative association of cancer worry with age. Possible explanations include greater familiarity with cancer and cancer outcomes in others (including positive ones), or less fear of cancer outcomes such as disability and death due to advanced age. Some studies have shown that older adults are indeed less fearful of death [34], and 40% of older adults in England believe that cancer is a good way to die [35]. Unlike previous studies [16, 27], we found that general cancer worry was lower among those from BAME backgrounds. However, levels of worry vary between ethnic groups [26, 32, 36], and may thus depend on the representation of specific ethnic groups in the sample. We could not explore this further due to small numbers in the ethnic groups.

In terms of the specific cancer worries, more people would be worried about the emotional and physical consequences of a cancer diagnosis than about the social consequences, although the latter were still reported by a fifth to half the population. This is the first study to examine specific cancer worries in the general population, although a study in breast cancer survivors and a qualitative review of cancer worries in cancer screening also found higher anticipation of treatment and death worries than worries about cancer’s social implications [20, 23]. Many people believe that ‘a diagnosis of cancer is a death sentence’ and that ‘cancer treatment is worse than the cancer itself’, which may explain this finding [37, 38]. We also noted the high prevalence of worry about financial consequences (76% would worry at least slightly), despite healthcare in England being provided free at the point of delivery via the National Health Service. Cancer patients often incur many indirect costs, however, such as for transportation, childcare, and lost wages [39], and the high prevalence of anticipated financial worry may reflect this.

This study has the following implications for future research. First, the population distribution of the specific worries about cancer was similar to that of general cancer worry, except for ethnicity. While we found no ethnic differences in worries about emotional and physical consequences, those from BAME backgrounds worried more about the social consequences of a cancer diagnosis. This could reflect cancer being taboo or stigmatised in some ethnic minority populations [40–42], and may help explain their lower uptake of cancer screening [43–45], and tendency to delay help-seeking for symptoms [46]. Future research into the behavioural effects of cancer worry in ethnic minority populations may benefit from distinguishing general cancer worry from specific worries about the social consequences of a cancer diagnosis.

Secondly, previous studies suggest that general cancer worry sometimes motivates help-seeking and attendance at cancer screening [10], but specific cancer worries may act as a deterrent [11, 23]. Although we did not assess the behavioural associations of the cancer worries included in this study, we did show that general cancer worry and specific cancer worries are only moderately correlated, and it may be important to distinguish them when assessing their behavioural effects. For example, behavioural theories such as the EPPM [14] would predict that the behavioural responses for general cancer worry and specific worries may be different: general cancer worry may motivate cancer screening attendance to obtain reassurance to deal with the threat of cancer, while fears about cancer treatment may motivate avoidance of screening to avoid a diagnosis, thereby dealing with the threat of cancer treatment. Given that 50% of older adults in the UK believe that most cancer treatment is worse than the cancer itself [38], distinguishing between the specific origins of cancer worry may help determine when cancer worry acts as a motivator and when it acts as a deterrent to cancer preventive behaviours. Assessing the behavioural effects of specific cancer worries was outside the scope of this study, however, and further research into these behavioural effects is needed.

Our study had some limitations. The specific worry items used were from a scale that had been previously developed and validated with breast cancer patients [20]. Although we used cognitive interviewing and an online pilot study to ensure items were clear and relevant to people without a cancer diagnosis, more work is needed to fully validate the scale for use in the general population. This study is only a first step in the exploration of specific cancer worries in the general population, and future research into specific cancer worries and their behavioural effects would benefit from further validation of this scale. Furthermore, a substantial proportion of respondents (7%) had missing data on the specific cancer worry items, which could have influenced estimates of their prevalence and population distribution. However, if those who worry are more likely to avoid answering these questions, then our prevalence estimates may be an underestimate. The cross-sectional nature of this study prevents any conclusions about temporal or causal relationships (such as whether cancer worry decreases with age), and longitudinal studies would be needed to examine how cancer worries evolve over time. Cancer worries may be affected by family history of cancer, but we were unable to measure this in the current study and future studies may want to explore this relationship. Finally, we aimed to examine whether there were differences in the prevalence and sociodemographic distribution of twelve specific worries about cancer. We did not specify a specific type of cancer, although the importance of these worries may vary by cancer type, for example, depending on the treatment options and survivability of a particular cancer type. Although this was outside of the scope of the current study, future studies could explore whether the prevalence of specific cancer worries varies by cancer type.

Conclusion

In conclusion, many aspects of cancer may evoke worry in the general population, including general worry about getting cancer and anticipated worries about the emotional, physical, and social consequences of a cancer diagnosis. This study can serve as a starting point to examine the behavioural effects of different cancer worries, and may ultimately help allay undue worries in those who are deterred by them.

Footnotes
1

In population research, the terms ‘cancer fear’ and ‘cancer worry’ are often used interchangeably. In clinical psychology, ‘fear’ refers to the emotional response to an immediate and observable threat and ‘worry’ refers to a more cognitive process where the threat is often anticipatory in nature [Rachman, S. Anxiety, 2nd ed. Hove: Psychology Press; 2004]. Consistent with these definitions, we will use the term ‘cancer worry’ to describe the negative emotional reaction to the threat of cancer in an asymptomatic population, except when referring to previous studies, where we will use the term that is used by the authors.

 

Abbreviations

ABACUS: 

Attitudes, Behaviour and Cancer UK Survey

BAME: 

Black, Asian, and Minority Ethnic

CARS: 

Concerns About Recurrence Scale

EPPM: 

Extended Parallel Process Model

SES: 

Socioeconomic status

Declarations

Acknowledgements

We would like to acknowledge the intellectual contribution made by Professor Wardle, who sadly passed away before this study was completed, and who is much missed by all her students and colleagues.

Funding

This work was supported by a programme grant from Cancer Research UK awarded to Professor Jane Wardle (C1418/A14134), which supported Charlotte Vrinten and Dr. Jo Waller, and a CRUK fellowship awarded to Dr. Jo Waller (C7492/A17219) which supported Dr. Jo Waller and Dr. Laura Marlow. Cancer Research UK were not involved in the design of this study; the collection, analysis, or interpretation of the results; in the writing of this manuscript, or in the decision to submit for publication.

Availability of data and materials

The datasets used and/or analysed during the current study are available from the corresponding author on reasonable request.

Authors’ contributions

CV and JW conceived of the study and designed the survey, with input from LAVM. CV and JW were responsible for data acquisition. PJM and CV planned the statistical analyses, which were conducted by CV with assistance from PJM. PJM drafted the manuscript, with input from CV. All authors read and approved the final manuscript before submission.

Ethics approval and consent to participate

Ethics approval for this study was obtained from the UCL Research Ethics Committee (registration number 5771/002) and all participants gave verbal consent to participate at the start of the survey.

Consent for publication

Not applicable

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Behavioural Science and Health, UCL, Gower Street, London, WC1E 6BT, UK

References

  1. Ferrer RA, Portnoy DB, Klein WM. Worry and risk perceptions as independent and interacting predictors of health protective behaviors. J Health Commun. 2013;18:397–409.View ArticlePubMedGoogle Scholar
  2. Persoskie A, Ferrer RA, Klein WM. Association of cancer worry and perceived risk with doctor avoidance: an analysis of information avoidance in a nationally representative US sample. J Behav Med. 2014;37:977–87.View ArticlePubMedGoogle Scholar
  3. Vrinten C, Waller J, Von Wagner C, Wardle J. Cancer fear: facilitator and deterrent to participation in colorectal cancer screening. Cancer Epidemiol Biomark Prev. 2015;24:400–5.View ArticleGoogle Scholar
  4. Hay JL, Buckley TR, Ostroff JS. The role of cancer worry in cancer screening: a theoretical and empirical review of the literature. Psychooncology. 2005;14:517–34.View ArticlePubMedGoogle Scholar
  5. Lerman C, Rimer BK, Daly M, Lustbader E, Sands C, Balshem A, Masny A, Engstrom P. Recruiting high risk women into a breast cancer health promotion trial. Cancer Epidemiol Biomark Prev. 1994;3:271–6.Google Scholar
  6. McCaul KD, Schroeder DM, Reid PA. Breast cancer worry and screening: some prospective data. Health Psychol. 1996;15:430–3.View ArticlePubMedGoogle Scholar
  7. Moser RP, McCaul K, Peters E, Nelson W, Marcus SE. Associations of perceived risk and worry with cancer health-protective actions data from the health information National Trends Survey (HINTS). J Health Psychol. 2007;12:53–65.View ArticlePubMedGoogle Scholar
  8. Gramling R, Anthony D, Frierson G, Bowen D. The cancer worry chart: a single-item screening measure of worry about developing breast cancer. Psychooncology. 2007;16:593–7.View ArticlePubMedGoogle Scholar
  9. Champion VL, Skinner CS, Menon U, Rawl S, Giesler RB, Monahan P, Daggy J. A breast cancer fear scale: psychometric development. J Health Psychol. 2004;9:753–62.View ArticlePubMedGoogle Scholar
  10. Hay JL, McCaul KD, Magnan RE. Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidence. Prev Med. 2006;42:401–8.View ArticlePubMedGoogle Scholar
  11. Balasooriya-Smeekens C, Walter FM, Scott S. The role of emotions in time to presentation for symptoms suggestive of cancer: a systematic literature review of quantitative studies. Psychooncology. 2015;24:1594–604.View ArticlePubMedGoogle Scholar
  12. Dubayova T, van Dijk JP, Nagyova I, Rosenberger J, Havlikova E, Gdovinova Z, Middel B, Groothoff JW. The impact of the intensity of fear on patient's delay regarding health care seeking behavior: a systematic review. Int J Public Health. 2010;55:459–68.View ArticlePubMedPubMed CentralGoogle Scholar
  13. Consedine NS, Magai C, Krivoshekova YS, Ryzewicz L, Neugut I. Fear, anxiety, worry, and breast screening behavior: a critical review. Cancer Epidemiol Biomark Prev. 2004;13:501–10.Google Scholar
  14. Witte K. Putting the fear back into fear appeals: the extended parallel process model. Commun Monogr. 1992;59:329–49.View ArticleGoogle Scholar
  15. Rogers RW. Cognitive and physiological processes in fear appeals and attitude change: a revised theory of protection motivation. In: Cacioppo JT, Petty RE (eds). Social Psychophysiology: a sourcebook. GuilfordPublications; 1983.Google Scholar
  16. Consedine NS, Adjei BA, Ramirez PM, McKiernan JM. An object lesson: source determines the relations that trait anxiety, prostate cancer worry, and screening fear hold with prostate screening frequency. Cancer Epidemiol Biomark Prev. 2008;17:1631–9.View ArticleGoogle Scholar
  17. Ahmad AS, Ormiston-Smith N, Sasieni PD. Trends in the lifetime risk of developing cancer in great Britain: comparison of risk for those born from 1930 to 1960. Br J Cancer. 2015;112:943–7.View ArticlePubMedPubMed CentralGoogle Scholar
  18. Herschbach P, Berg P, Dankert A, Duran G, Engst-Hastreiter U, Waadt S, Keller M, Ukat R, Henrich G. Fear of progression in chronic diseases: psychometric properties of the fear of progression questionnaire. J Psychosom Res. 2005;58:505–11.View ArticlePubMedGoogle Scholar
  19. Simard S, Savard J. Fear of cancer recurrence inventory: development and initial validation of a multidimensional measure of fear of cancer recurrence. Support Care Cancer. 2008;17:241–51.View ArticlePubMedGoogle Scholar
  20. Vickberg SMJ. The concerns about recurrence scale (CARS): a systematic measure of women’s fears about the possibility of breast cancer recurrence. Ann Behav Med. 2003;25:16–24.View ArticlePubMedGoogle Scholar
  21. Facione NC. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med. 1993;36:1521–34.View ArticlePubMedGoogle Scholar
  22. Smith LK, Pope C, Botha JL. Patients’ help-seeking experiences and delay in cancer presentation: a qualitative synthesis. Lancet. 2005;366:825–31.View ArticlePubMedGoogle Scholar
  23. Vrinten C, McGregor LM, Heinrich M, Wagner C, Waller J, Wardle J, Black GB. What do people fear about cancer? A systematic review and meta-synthesis of cancer fears in the general population. Psychooncology. 2016; E-pub 19 September 2016.Google Scholar
  24. Health Information National Trends Survey (HINTS) 2003, 2005, and 2008 [Available from http://hints.cancer.gov/default.aspx].
  25. Han PK, Moser RP, Klein WM. Perceived ambiguity about cancer prevention recommendations: associations with cancer-related perceptions and behaviours in a US population survey. Health Expect. 2007;10:321–36.View ArticlePubMedPubMed CentralGoogle Scholar
  26. McQueen A, Vernon SW, Meissner HI, Rakowski W. Risk perceptions and worry about cancer: does gender make a difference? J Health Commun. 2008;13:56–79.View ArticlePubMedGoogle Scholar
  27. Vrinten C, van Jaarsveld CH, Waller J, von Wagner C, Wardle J. The structure and demographic correlates of cancer fear. BMC Cancer. 2014;14:597.View ArticlePubMedPubMed CentralGoogle Scholar
  28. McCaul KD, Branstetter AD, O’Donnell SM, Jacobson K, Quinlan KB. A descriptive study of breast cancer worry. J Behav Med. 1998;21:565–79.View ArticlePubMedGoogle Scholar
  29. Andersen MR, Smith R, Meischke H, Bowen D, Urban N. Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomark Prev. 2003;12:314–20.Google Scholar
  30. National Readership Survey. Social Grade [Available from http://www.nrs.co.uk/nrs-print/lifestyle-and-classification-data/social-grade/].
  31. Sutton S, Bickler G, Sancho-Aldridge J, Saidi G. Prospective study of predictors of attendance for breast screening in inner London. J Epidemiol Commun Health. 1994;48:65–73.View ArticleGoogle Scholar
  32. Consedine NS, Magai C, Neugut AI. The contribution of emotional characteristics to breast cancer screening among women from six ethnic groups. Prev Med. 2004;38:64–77.View ArticlePubMedGoogle Scholar
  33. McLean CP, Anderson ER. Brave men and timid women? A review of gender differences in fear and anxiety. Clin Psychol Rev. 2009;29:496–505.View ArticlePubMedGoogle Scholar
  34. Wong PT, Reker GT, Gesser G. Death attitude profile-revised: a multidimensional measure of attitude toward death. In: Niemeyer R, editor. Death anxiety handbook: research, instrumentation, and application. Washington, DC: Taylor & Francis; 1994. p. 121–48.Google Scholar
  35. Vrinten C, Wardle J. Is cancer a good way to die? A population-based survey among middle-aged and older adults in the United Kingdom. Eur J Cancer. 2016;56:172–8.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Vrinten C, Wardle J, Marlow LA. Cancer fear and fatalism among ethnic minority women in the United Kingdom. Br J Cancer. 2016;114:597–604.View ArticlePubMedPubMed CentralGoogle Scholar
  37. Moser RP, Arndt J, Han PK, Waters EA, Amsellem M, Hesse BW. Perceptions of cancer as a death sentence: prevalence and consequences. J Health Psychol. 2014;19:1518–24.View ArticlePubMedGoogle Scholar
  38. Quaife SL, Winstanley K, Robb KA, Simon AE, Ramirez AJ, Forbes LJ, Brain KE, Gavin A, Wardle J. Socioeconomic inequalities in attitudes towards cancer: an international cancer benchmarking partnership study. Eur J Cancer Prev. 2015;24:253–60.View ArticlePubMedPubMed CentralGoogle Scholar
  39. Kale HP, Carroll NV. Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer. 2016;122:283–9.View ArticlePubMedGoogle Scholar
  40. Marlow LA, Waller J, Wardle J. Barriers to cervical cancer screening among ethnic minority women: a qualitative study. J Fam Plan Reprod Health Care. 2015;41:248–54.View ArticleGoogle Scholar
  41. Randhawa G, Owens A. The meanings of cancer and perceptions of cancer services among south Asians in Luton, UK. Br J Cancer. 2004;91:62–8.View ArticlePubMedPubMed CentralGoogle Scholar
  42. Robb KA, Solarin I, Power E, Atkin W, Wardle J. Attitudes to colorectal cancer screening among ethnic minority groups in the UK. BMC Public Health. 2008;8:34.View ArticlePubMedPubMed CentralGoogle Scholar
  43. Moser K, Patnick J, Beral V. Inequalities in reported use of breast and cervical screening in great Britain: analysis of cross sectional survey data. BMJ. 2009;338:b2025.View ArticlePubMedPubMed CentralGoogle Scholar
  44. Szczepura A, Price C, Gumber A. Breast and bowel cancer screening uptake patterns over 15 years for UK south Asian ethnic minority populations, corrected for differences in socio-demographic characteristics. BMC Public Health. 2008;8:346.View ArticlePubMedPubMed CentralGoogle Scholar
  45. Von Wagner C, Baio G, Raine R, Snowball J, Morris S, Atkin W, Obichere A, Handley G, Logan RF, Rainbow S. Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England. Int J Epidemiol. 2011;40:712–8.View ArticlePubMedGoogle Scholar
  46. Macleod U, Mitchell ED, Burgess C, Macdonald S, Ramirez AJ. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer. 2009;101(Suppl 2):S92–S101.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement

BMC Cancer

ISSN: 1471-2407

Contact us